Carboplatin Plus Etoposide With or Without MPDL3280A in Untreated Extensive Stage Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2017-05-09
Target enrollment:
Participant gender:
Summary
This is an open-label study with two parts, a Phase I study and a randomized Phase II study.
This study will be conducted at approximately ten sites in the United States. Approximately
178 patients will be enrolled in this trial.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Giuseppe Giaccone
Collaborators:
Memorial Sloan Kettering Cancer Center Vanderbilt University